These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20145146)

  • 1. Comment re: Intratumoral immune reaction in human colorectal cancer.
    Speetjens FM; Kuppen PJ
    Cancer Res; 2010 Feb; 70(4):1741; author reply 1741. PubMed ID: 20145146
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
    Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
    Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progression in tumor-infiltration lymphocytic cells in colorectal cancer].
    Zhai ZW; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):797-800. PubMed ID: 23980054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
    Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
    Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune response and colorectal cancer].
    Tougeron D; Fauquembergue E; Latouche JB
    Bull Cancer; 2013 Mar; 100(3):283-94. PubMed ID: 23501583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.
    Houston AM; Michael-Robinson JM; Walsh MD; Cummings MC; Ryan AE; Lincoln D; Pandeya N; Jass JR; Radford-Smith GL; O'Connell J
    Hum Pathol; 2008 Feb; 39(2):243-50. PubMed ID: 17961631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
    Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma.
    Smyrk TC; Watson P; Kaul K; Lynch HT
    Cancer; 2001 Jun; 91(12):2417-22. PubMed ID: 11413533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The essential role of the in situ immune reaction in human colorectal cancer.
    Pagès F; Galon J; Fridman WH
    J Leukoc Biol; 2008 Oct; 84(4):981-7. PubMed ID: 18559950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunogenic process leading to cancer in the context of immunodeficiency.
    Hamelin R; Borie C; Raphaël M; Duval A
    Cell Cycle; 2004 Sep; 3(9):1130-2. PubMed ID: 15326397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic evolution of cancer cells.
    Boland CR; Goel A
    Semin Cancer Biol; 2005 Dec; 15(6):436-50. PubMed ID: 16055343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma.
    Bueter M; Gasser M; Schramm N; Lebedeva T; Tocco G; Gerstlauer C; Grimm M; Nichiporuk E; Thalheimer A; Thiede A; Meyer D; Benichou G; Waaga-Gasser AM
    Int J Oncol; 2006 Feb; 28(2):431-8. PubMed ID: 16391798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms.
    de la Cruz-Merino L; Henao Carrasco F; Vicente Baz D; Nogales Fernández E; Reina Zoilo JJ; Codes Manuel de Villena M; Pulido EG
    Clin Dev Immunol; 2011; 2011():174149. PubMed ID: 22162710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
    Atreya I; Neurath MF
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
    J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor infiltrating lymphocytes: indicators of tumor-related immune responses.
    Odunsi K; Old LJ
    Cancer Immun; 2007 Feb; 7():3. PubMed ID: 17311362
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.